Risk factors for mortality in patients with Acinetobacter baumannii bacteremia

Infection and Chemotherapy

Volumn 45, Issue 3, 2013, Pages 325-330

  Park, Se Yoon ^a   Choo, Jin Woo ^a   Kwon, Soon Ha ^a   Yu, Shi Nae ^a   Lee, Eun Jung ^a   Kim, Tae Hyong ^a   Choo, Eun Ju ^a   Jeon, Min Huok ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

Author keywords

Acinetobacter baumannii; Bacteremia; Mortality

Indexed keywords

CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BACTERIAL PNEUMONIA; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; FEMALE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK FACTOR;

EID: 84887518737     PISSN: 20932340     EISSN: 20926448     Source Type: Journal    
DOI: 10.3947/ic.2013.45.3.325     Document Type: Article

References (16)

1. Jeon MH, Park WB, Kim SR, Chun HK, Han SH, Bang JH, Park ES, Jeong SY, Eom JS, Kim YK, Kim HB, Lee KY, Choi HJ, Kim HY, Kim KM, Sung JH, Uh Y, Chung HS, Kwon JW, Woo JH. Korean nosocomial infections surveillance system, intensive care unit module report: data summary from July 2010 through June 2011. Korean J Nosocomial Infect Control 2012;17:28-39.
2. Blot S, Vandewoude K, Colardyn F. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med 2003;29:471-5.
3. Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008;46:1254-63.
4. Tseng YC, Wang JT, Wu FL, Chen YC, Chie WC, Chang SC. Prognosis of adult patients with bacteremia caused by extensively resistant Acinetobacter baumannii. Diagn Microbiol Infect Dis 2007;59:181-90.
5. Kim SY, Jung JY, Kang YA, Lim JE, Kim EY, Lee SK, Park SC, Chung KS, Park BH, Kim YS, Kim SK, Chang J, Park MS. Risk factors for occurrence and 30-day mortality for carbapenem- resistant Acinetobacter baumannii bacteremia in an intensive care unit. J Korean Med Sci 2012;27:939-47.
6. Cisneros JM, Reyes MJ, Pachón J, Becerril B, Caballero FJ, García-Garmendía JL, Ortiz C, Cobacho AR. Bacteremia due to Acinetobacter baumannii: epidemiology, clinical findings, and prognostic features. Clin Infect Dis 1996; 22:1026-32.
7. Wareham DW, Bean DC, Khanna P, Hennessy EM, Krahe D, Ely A, Millar M. Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance. Eur J Clin Microbiol Infect Dis 2008;27:607-12.
8. Kim YJ, Kim SI, Hong KW, Kim YR, Park YJ, Kang MW. Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: impact of appropriate antimicrobial therapy. J Korean Med Sci 2012;27:471-5.
9. Sheng WH, Liao CH, Lauderdale TL, Ko WC, Chen YS, Liu JW, Lau YJ, Wang LH, Liu KS, Tsai TY, Lin SY, Hsu MS, Hsu LY, Chang SC. A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem- resistant Acinetobacter baumannii. Int J Infect Dis 2010;14:e764-9.
10. Wikler MA. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard. 8th ed. Wayne, Pa: CLSI; 2008.
11. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-40.
12. Lee NY, Lee HC, Ko NY, Chang CM, Shih HI, Wu CJ, Ko WC. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol 2007;28:713-9.
13. Lee YT, Kuo SC, Yang SP, Lin YT, Tseng FC, Chen TL, Fung CP. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection. Clin Infect Dis 2012; 55:209-15.
14. Choi JY, Park YS, Kim CO, Park YS, Yoon HJ, Shin SY, Kim YA, Song YG, Yong D, Lee K, Kim JM. Mortality risk factors of Acinetobacter baumannii bacteraemia. Intern Med J 2005;35:599-603.
15. Routsi C, Pratikaki M, Platsouka E, Sotiropoulou C, Nanas S, Markaki V, Vrettou C, Paniara O, Giamarellou H, Roussos C. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes. Infection 2010;38:173-80.
16. Cisneros JM, Rodríguez-Baño J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 2002;8:687-93.